The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
New article in Clinical Epigenetics!
June 30, 2022 5:22 PM
PharmaTox researchers have published a new article, "Low reliability of DNA methylation across Illumina Infinium platforms in cord blood: implications for replication studies and meta-analyses of prenatal exposures", in Clinical Epigenetics. Read it here.
New paper from PharmaTox researchers!
June 26, 2022 2:23 PM
PharmaTox researchers have published a new paper in Toxicology and Applied Pharmacology: "Paracetamol perturbs neuronal arborization and disrupts the cytoskeletal proteins SPTBN1 and TUBB3 in both human and chicken in vitro models". Read it here.
Disputation: Gerd Marie Eskerud Harris
June 7, 2022 2:20 PM
PharmaTox doctoral candidate Gerd Marie Eskerud Harris defends her thesis "Migraine pharmacotherapy during pregnancy: Utilization patterns and associations with child neurodevelopment" for the degree of Philosophiae Doctor.
New article in JAMA Network Open!
June 7, 2022 2:17 PM
PharmaTox researchers set out to answer the question "Is prenatal exposure to triptans associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) in offspring?".
PharmaTox-video med Geir Kjetil Sandve og Harald Eia
Apr. 6, 2022 7:01 AM
Harald Eia lurer på om det er sånn at man kjører masse data inn i datamaksinen, og så finner man at barnet får tannstein dersom mor brukte briller i svangerskapet. Geir Kjetil Sandve svarer.